BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18923998)

  • 21. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms.
    Chen CJ; Wang CJ
    Cancer Res; 1990 Sep; 50(17):5470-4. PubMed ID: 2386951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of hepatitis B surface antigen carrier status among residents in the endemic area of chronic arsenicism in Taiwan.
    Lu JN; Chen CJ
    Anticancer Res; 1991; 11(1):229-33. PubMed ID: 2018356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study on distribution of endemic arsenism in China].
    Jin Y; Liang C; He G; Cao J
    Wei Sheng Yan Jiu; 2003 Nov; 32(6):519-40. PubMed ID: 14963897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150 μg/L) well water arsenic levels--an exploration of the dose-response Poisson analysis.
    Lamm SH; Robbins SA; Zhou C; Lu J; Chen R; Feinleib M
    Regul Toxicol Pharmacol; 2013 Feb; 65(1):147-56. PubMed ID: 23137931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan.
    Huang YL; Hsueh YM; Huang YK; Yip PK; Yang MH; Chen CJ
    Sci Total Environ; 2009 Apr; 407(8):2608-14. PubMed ID: 19187952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discontinuity in the cancer slope factor as it passes from high to low exposure levels--arsenic in the BFD-endemic area.
    Lamm SH; Robbins S; Chen R; Lu J; Goodrich B; Feinleib M
    Toxicology; 2014 Dec; 326():25-35. PubMed ID: 25241138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic health effects in people exposed to arsenic via the drinking water: dose-response relationships in review.
    Yoshida T; Yamauchi H; Fan Sun G
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):243-52. PubMed ID: 15276403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk characterization and exposure assessment in arseniasis-endemic areas of Taiwan.
    Ling MP; Liao CM
    Environ Int; 2007 Jan; 33(1):98-107. PubMed ID: 17014909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan.
    Tseng CH; Huang YK; Huang YL; Chung CJ; Yang MH; Chen CJ; Hsueh YM
    Toxicol Appl Pharmacol; 2005 Aug; 206(3):299-308. PubMed ID: 16039941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxicokinetics/toxicodynamics of arsenic for farmed juvenile milkfish Chanos chanos and human consumption risk in BFD-endemic area of Taiwan.
    Chou BY; Liao CM; Lin MC; Cheng HH
    Environ Int; 2006 May; 32(4):545-53. PubMed ID: 16513169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between chronic exposure to arsenic and slow nerve conduction velocity among adolescents in Taiwan.
    Tseng HP; Wang YH; Wu MM; The HW; Chiou HY; Chen CJ
    J Health Popul Nutr; 2006 Jun; 24(2):182-9. PubMed ID: 17195559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arsenic contamination and arsenicosis in China.
    Sun G
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):268-71. PubMed ID: 15276405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases.
    Wu MM; Kuo TL; Hwang YH; Chen CJ
    Am J Epidemiol; 1989 Dec; 130(6):1123-32. PubMed ID: 2589305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological characteristics and survival outcome of arsenic related bladder cancer in taiwan.
    Chen CH; Chiou HY; Hsueh YM; Chen CJ; Yu HJ; Pu YS
    J Urol; 2009 Feb; 181(2):547-52; discussion 553. PubMed ID: 19084863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan.
    Huang YK; Tseng CH; Huang YL; Yang MH; Chen CJ; Hsueh YM
    Toxicol Appl Pharmacol; 2007 Jan; 218(2):135-42. PubMed ID: 17173945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association between arsenic exposure from drinking water and cerebrovascular disease mortality in Taiwan.
    Cheng TJ; Ke DS; Guo HR
    Water Res; 2010 Nov; 44(19):5770-6. PubMed ID: 20561663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic arsenic exposure and its adverse health effects in Taiwan: a paradigm for management of a global environmental problem.
    Lan CC; Yu HS; Ko YC
    Kaohsiung J Med Sci; 2011 Sep; 27(9):411-6. PubMed ID: 21914529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and epidemiological features of patients with genitourinary tract tumour in a blackfoot disease endemic area of Taiwan.
    Tan LB; Chen KT; Guo HR
    BJU Int; 2008 Jul; 102(1):48-54. PubMed ID: 18445081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An overview on peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan.
    Tseng CH
    Angiology; 2002; 53(5):529-37. PubMed ID: 12365859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water.
    Marshall G; Ferreccio C; Yuan Y; Bates MN; Steinmaus C; Selvin S; Liaw J; Smith AH
    J Natl Cancer Inst; 2007 Jun; 99(12):920-8. PubMed ID: 17565158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.